MSB 1.34% $1.51 mesoblast limited

Cell Therapy News/Articles, page-5198

  1. 1,719 Posts.
    lightbulb Created with Sketch. 461
    Must of missed your post, Imback.
    you answered my question...
    No one would throw away $300k in the hopes to stop a rival/competitor if they didn’t think they had a good chance for FDA approval.
    Thats a great sign right there for mesoblast I reckon!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.